About Alligator Bioscience
Alligator Bioscience is a company based in Lund (Sweden) founded in 2001. It operates as a HealthTech. Alligator Bioscience has raised $10 million across 2 funding rounds from investors including Vinnova. Alligator Bioscience offers products and services including Mitazalimab, ATOR-4066, and ALG.APV-527. Alligator Bioscience operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others.
- Headquarter Lund, Sweden
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alligator Bioscience Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 2 rounds
-
Latest Funding Round
$55.05 K (USD), Grant
Oct 05, 2018
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alligator Bioscience
Alligator Bioscience offers a comprehensive portfolio of products and services, including Mitazalimab, ATOR-4066, and ALG.APV-527. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Developed as a tumor-directed immunotherapy for cancer treatment.
Designed as an antibody-based solution for cancer therapy.
Created for targeted cancer treatment using antibody technology.
Unlock access to complete
Unlock access to complete
Funding Insights of Alligator Bioscience
Alligator Bioscience has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $55.05 thousand completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $55,050
-
First Round
First Round
(01 Oct 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2018 | Amount | Grant - Alligator Bioscience | Valuation |
investors |
|
| Oct, 2015 | Amount | Series A - Alligator Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alligator Bioscience
Alligator Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Vinnova. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided to Swedish companies across sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alligator Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alligator Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alligator Bioscience Comparisons
Competitors of Alligator Bioscience
Alligator Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alligator Bioscience
Frequently Asked Questions about Alligator Bioscience
When was Alligator Bioscience founded?
Alligator Bioscience was founded in 2001 and raised its 1st funding round 14 years after it was founded.
Where is Alligator Bioscience located?
Alligator Bioscience is headquartered in Lund, Sweden.
Is Alligator Bioscience a funded company?
Alligator Bioscience is a funded company, having raised a total of $10M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Oct 01, 2015.
What does Alligator Bioscience do?
Alligator Bioscience is engaged in the development of antibody-based pharmaceuticals for cancer treatment. The company is specialized in tumor-directed immunotherapies, particularly agonistic mono- and bispecific antibodies. Solutions are developed within the biotechnology sector, targeting innovative approaches to combat metastatic cancers like pancreatic cancer. Research and development efforts are centered on a pipeline of candidates such as Mitazalimab, ATOR-4066, and ALG.APV-527, aimed at improving patient outcomes through advanced therapeutic technologies.
Who are the top competitors of Alligator Bioscience?
Alligator Bioscience's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Alligator Bioscience offer?
Alligator Bioscience offers Mitazalimab, ATOR-4066, and ALG.APV-527.
Who are Alligator Bioscience's investors?
Alligator Bioscience has 1 investor. Key investors include Vinnova.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.